Lam Research stock jumps 6% as chip-tool rally builds on BofA AI call ahead of CES

Lam Research stock jumps 6% as chip-tool rally builds on BofA AI call ahead of CES

New York, January 5, 2026, 11:54 (EST) — Regular session

  • Lam Research shares rose about 6.4% in late-morning trade, outpacing the broader semiconductor ETF.
  • A Bank of America note flagged Lam among seven AI-linked chip and equipment names for 2026.
  • Traders are watching CES this week and Lam’s next earnings update later this month.

Lam Research stock climbed about 6.4% to $196.90 in late-morning New York trading on Monday, valuing the chip equipment maker at about $162 billion. The shares touched $198.34 earlier in the session, market data showed.

The move matters because investors treat chip-tool suppliers as a direct read on capital spending by chipmakers building capacity for AI workloads. Lam sells the machines used to etch and deposit materials on silicon wafers, a key step in making advanced chips and memory.

Optimism got a lift from a Bank of America note on Monday that highlighted Lam among seven stocks it sees best positioned for 2026. “The AI buildout remains ‘mid-cycle’,” analyst Vivek Arya wrote, arguing CES could reinforce new drivers in robotics and on-device AI alongside continued cloud expansion. 1

The gains were not isolated. Applied Materials rose about 6.9%, KLA gained 7.2% and ASML’s U.S. shares added around 6.2%, while the iShares Semiconductor ETF was up roughly 2.5%.

In chipmaking equipment, investors watch memory spending closely because it can swing faster than demand for logic chips such as CPUs. Bernstein Research upgraded ASML on Monday, arguing the market underestimates upside tied to DRAM — the main memory used in servers — as makers ramp capital expenditure to meet AI-server demand, MarketWatch reported. 2

Lam and its peers are often viewed as “picks-and-shovels” for the AI buildout, benefiting when customers expand factories or upgrade processes. Those budgets can accelerate when cloud companies add data center capacity, and they can slow abruptly when chip inventories rise.

Still, the trade can cut both ways. Any pullback in cloud capital spending or a turn in the memory cycle could pressure tool orders, and tighter U.S. export restrictions remain a wildcard for equipment sales into China.

Investors have a near-term catalyst this week at CES in Las Vegas, which runs Jan. 6-9, according to the show’s organizer. 3

Reuters reported that Nvidia CEO Jensen Huang and AMD CEO Lisa Su are among key speakers as companies push deeper into AI-powered systems and robotics — themes that can swing sentiment across the semiconductor supply chain. 4

For Lam, the next company-specific test comes with its quarterly report, due Jan. 28 according to Investing.com. Traders will look for commentary on 2026 wafer-fab equipment spending, the pace of memory investment, and demand trends in China. 5

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Coinbase stock jumps after Goldman upgrade as Bitcoin trades near $94,000 — what investors watch next
Previous Story

Coinbase stock jumps after Goldman upgrade as Bitcoin trades near $94,000 — what investors watch next

IREN Limited stock jumps 10% as bitcoin climbs; traders eye U.S. jobs report next
Next Story

IREN Limited stock jumps 10% as bitcoin climbs; traders eye U.S. jobs report next

Go toTop